RE: Over promised, under delivered.1 Nov 2025 12:55
I think any deal will be well in to next year. 50/50 whether they will get anything over the line, bear in mind their product was unsuccessful at the last trial so it will be a big risk for Pharmas to jump in now. I suspect, after due diligence, that they will probably hold back until a new trial is conducted.
Also, don’t forget that a chunky deal is already priced in at £60m mcap…. So there is a long way to fall if there is any negative news.